Skip to search formSkip to main contentSkip to account menu

SU-5416

Known as: SU 5416, SU5416, Sugen 5416 
National Institutes of Health

Related topics

Related topics

2 relations
SU 6668

Broader (1)

Semaxinib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Study of differences in the VEGFR2 inhibitory activities between semaxanib and SU5205 using 3D-QSAR, docking, and molecular dynamics simulations.
Highly Cited
2009
Highly Cited
2009
Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3.
Internal tandem duplication mutations in the Flt3 tyrosine kinase gene (ITD-Flt3) and overexpression of Survivin are frequently… 
2007
2007
Inflammatory Breast Cancer as a Model Disease to Study Tumor Angiogenesis: Results of a Phase IB Trial of Combination SU5416 and Doxorubicin
Purpose: We used inflammatory breast cancer (IBC) as a model disease to investigate biological changes associated with an… 
Highly Cited
2006
Highly Cited
2006
The anti‐angiogenic VEGF isoform VEGF165b transiently increases hydraulic conductivity, probably through VEGF receptor 1 in vivo
Vascular endothelial growth factor (VEGF) is the principal agent that increases microvascular permeability during physiological… 
Highly Cited
2004
Highly Cited
2004
SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway.
2003
2003
Gas phase electronic spectra of the linear carbon chains HC2n+1H (n=3–6,9)
The B 3Σu−←X 3Σg− transitions of HC13H and HC19H have been measured in the gas phase, exhibiting broad, Lorentzian shaped bands… 
Highly Cited
2002
Highly Cited
2002
Bradykinin-related compounds as new drugs for cancer and inflammation.
Bradykinin (BK) (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) is an important growth factor for small-cell lung cancer (SCLC) and… 
Highly Cited
2001
Highly Cited
2001
Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells.
Six indolinone tyrosine kinase inhibitors were characterized for their ability to inhibit Kit kinase and for their effects on the… 
Review
2001
Review
2001
Angiogenesis inhibitors in the treatment of lung cancer.
Highly Cited
1967
Highly Cited
1967
ASYMPTOTIC SU(3) AND VECTOR MESON DECAYS.
We have derived several sum rules based upon the assumption that the SU(3) group will be exact at infinite energy. In this way… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)